首页> 美国卫生研究院文献>Indian Journal of Surgical Oncology >Differences in Perioperative Outcomes Between Right and Left Hepatic Lobectomy
【2h】

Differences in Perioperative Outcomes Between Right and Left Hepatic Lobectomy

机译:左右肝叶切除术围手术期的差异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The safety of hepatic resection is well documented, but outcome studies comparing right and left hepatic lobectomy are sparse, especially in the context of malignancy. This study analyzes the differences in outcomes between right and left hepatic lobectomy in patients with malignant diagnoses. All patients undergoing right and left hepatic lobectomies for malignancy were extracted from the National Surgical Quality Improvement Program (NSQIP) database (2005–2010). The data was analyzed to determine differences in perioperative mortality and morbidity between the two groups. A total of 1680 patients who underwent right or left hepatic lobectomy for malignant diagnoses were identified. Patients undergoing right hepatic lobectomy had a four-fold increase in perioperative mortality, compared to left lobectomy (p < 0.0001). Mortality in right lobectomy patients increased incrementally with age, with a 12-fold increase in patients > 81 years of age. Patients undergoing right lobectomy also experienced a statistically significant increase in morbidity involving several systems (infectious, pulmonary, cardiac and renal). The results of our study demonstrate that patients undergoing right hepatic lobectomy for malignancy experience a significantly higher incidence of mortality and multi-system morbidity when compared to left lobectomy. This information will be crucial for pre-operative risk-stratification of patients undergoing hepatic resection for malignancy.
机译:肝切除术的安全性已有充分文献证明,但比较右肝叶和左肝叶切除术的结局研究很少,尤其是在恶性肿瘤的情况下。本研究分析了恶性诊断患者左右肝叶切除术的结局差异。从美国国家外科质量改善计划(NSQIP)数据库(2005-2010)中提取所有因右肝和左肝叶切除而接受恶性肿瘤治疗的患者。分析数据以确定两组之间围手术期死亡率和发病率的差异。总共确定了1680例接受了右或左肝叶切除术以进行恶性诊断的患者。与左肺叶切除术相比,接受右肝叶切除术的患者围手术期死亡率增加了四倍(p <0.0001)。右肺叶切除术患者的死亡率随着年龄的增长而增加,年龄> 81岁的患者的死亡率增加了12倍。接受右肺叶切除术的患者的发病率在统计学上也有显着增加,涉及多个系统(感染性,肺部,心脏和肾脏)。我们的研究结果表明,与左肺叶切除术相比,接受右肝叶切除术治疗恶性肿瘤的患者的死亡率和多系统发病率明显更高。该信息对于进行肝切除恶性肿瘤患者的术前风险分层至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号